Similar articles for PMID: 22086897

Year	Number of Results
1999	1
2002	1
2003	1
2005	4
2006	1
2007	2
2008	1
2009	2
2010	5
2011	13
2012	10
2013	9
2014	4
2015	9
2016	11
2017	9
2018	7
2019	7
2020	11
2021	2
2022	0

1

Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks.

Timms JF, Menon U, Devetyarov D, Tiss A, Camuzeaux S, McCurrie K, Nouretdinov I, Burford B, Smith C, Gentry-Maharaj A, Hallett R, Ford J, Luo Z, Vovk V, Gammerman A, Cramer R, Jacobs I. Timms JF, et al. Cancer Genomics Proteomics. 2011 Nov-Dec;8(6):289-305. Cancer Genomics Proteomics. 2011. PMID: 22086897

2

Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.

Tiss A, Timms JF, Smith C, Devetyarov D, Gentry-Maharaj A, Camuzeaux S, Burford B, Nouretdinov I, Ford J, Luo Z, Jacobs I, Menon U, Gammerman A, Cramer R. Tiss A, et al. Int J Gynecol Cancer. 2010 Dec;20(9):1518-24. Int J Gynecol Cancer. 2010. PMID: 21370595

3

Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.

Clarke CH, Yip C, Badgwell D, Fung ET, Coombes KR, Zhang Z, Lu KH, Bast RC Jr. Clarke CH, et al. Gynecol Oncol. 2011 Sep;122(3):548-53. doi: 10.1016/j.ygyno.2011.06.002. Epub 2011 Jun 25. Gynecol Oncol. 2011. PMID: 21708402 Free PMC article.

4

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.

Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, Ryan A, Kalsi JK, Ainley C, Whetton AD, Menon U, Jacobs I, Graham RLJ. Russell MR, et al. Br J Cancer. 2017 Aug 22;117(5):666-674. doi: 10.1038/bjc.2017.199. Epub 2017 Jun 29. Br J Cancer. 2017. PMID: 28664912 Free PMC article. Clinical Trial.

5

Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.

Fortner RT, Schock H, Le Cornet C, Hüsing A, Vitonis AF, Johnson TS, Fichorova RN, Fashemi T, Yamamoto HS, Tjønneland A, Hansen L, Overvad K, Boutron-Ruault MC, Kvaskoff M, Severi G, Boeing H, Trichopoulou A, Papatesta EM, La Vecchia C, Palli D, Sieri S, Tumino R, Sacerdote C, Mattiello A, Onland-Moret NC, Peeters PH, Bueno-de-Mesquita HBA, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Navarro C, Ardanaz E, Larrañaga N, Nodin B, Jirström K, Idahl A, Lundin E, Khaw KT, Travis RC, Gunter M, Johansson M, Dossus L, Merritt MA, Riboli E, Terry KL, Cramer DW, Kaaks R. Fortner RT, et al. Int J Cancer. 2018 Apr 1;142(7):1355-1360. doi: 10.1002/ijc.31164. Epub 2017 Dec 11. Int J Cancer. 2018. PMID: 29159934 Free PMC article.

6

Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, Li B, Liu H, Lam KS. Leiserowitz GS, et al. Int J Gynecol Cancer. 2008 May-Jun;18(3):470-5. doi: 10.1111/j.1525-1438.2007.01028.x. Epub 2007 Jul 26. Int J Gynecol Cancer. 2008. PMID: 17655680 Free PMC article.

7

Serum peptide/protein profiling by mass spectrometry provides diagnostic information independently of CA125 in women with an ovarian tumor.

Callesen AK, Madsen JS, Iachina M, Vach W, Kruse TA, Jensen ON, Mogensen O. Callesen AK, et al. Cancer Biomark. 2010;6(2):73-82. doi: 10.3233/CBM-2009-0120. Cancer Biomark. 2010. PMID: 20571233

8

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.

Tcherkassova J, Abramovich C, Moro R, Chen C, Schmit R, Gerber A, Moro R. Tcherkassova J, et al. Tumour Biol. 2011 Aug;32(4):831-8. doi: 10.1007/s13277-011-0186-1. Epub 2011 May 28. Tumour Biol. 2011. PMID: 21625941 Free PMC article.

9

A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.

Leandersson P, Åkesson A, Hedenfalk I, Malander S, Borgfeldt C. Leandersson P, et al. PLoS One. 2020 Oct 19;15(10):e0240418. doi: 10.1371/journal.pone.0240418. eCollection 2020. PLoS One. 2020. PMID: 33075095 Free PMC article.

10

Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry.

Weiland F, Fritz K, Oehler MK, Hoffmann P. Weiland F, et al. Int J Mol Sci. 2012;13(8):9942-58. doi: 10.3390/ijms13089942. Epub 2012 Aug 9. Int J Mol Sci. 2012. PMID: 22949840 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed